Case Report: Contrasting BCL2 Upregulation With Venetoclax in a Case of Refractory Lymphomatoid Papulosis and Progressive Chronic Lymphocytic Leukemia
A 57-year-old man affected by high-risk progressive chronic lymphocytic leukemia (CLL), primary resistant to first-line chemoimmunotherapy, developed a type A lymphomatoid papulosis (LyP) during a second progression of CLL. The two blood tumor entities were clonally unrelated. LyP presented with a d...
Main Authors: | Valerio Guarente, Giovanni Martino, Erica Dorillo, Filomena De Falco, Chiara Rompietti, Daniele Sorcini, Mariangela Brogna, Valeria Cardinali, Stefano Ascani, Andrea Marra, Paolo Sportoletti |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-09-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.729106/full |
Similar Items
-
Angiocentric Lymphomatoid papulosis in a child: uncommon benign clinical entity with malignant histology
by: Kanthilatha Pai, et al.
Published: (2015-01-01) -
Type D lymphomatoid papulosis simulating aggressive epidermotropic cytotoxic lymphoma
by: Venkatraman Mani, et al.
Published: (2016-01-01) -
Lymphomatoid papulosis localized to the oral mucosa: case report and literature review
by: Bretsztajn S., et al.
Published: (2019-01-01) -
Lymphomatoid papulosis: a clinical and histopathologic review and follow-up study of 34 cases in Taiwan
by: Jheng-Wei Lin, et al.
Published: (2011-03-01) -
Lymphomatoid papulosis successfully managed with excimer laser maintenance therapy
by: Vidhatha Reddy, BA, et al.
Published: (2020-06-01)